PCSA
Processa Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.96
+3.16%Next report
Analyst consensus
- Next report date
- Oct 29, 2026
- EPS estimate
- -$1.00
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$1.19
- EPS estimate
- -$1.00
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -292.2%
- Revenue beats (12Q)
- —
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | -$1.00 | -$1.19 | Miss -19.00% | — |
| May 7, 2026 | -$1.00 | -$1.29 | Miss -29.00% | — |
| Mar 19, 2026 | -$1.50 | -$19 | Miss -1133.33% | — |
| Nov 6, 2025 | -$2.00 | -$1.75 | Beat 12.50% | — |
| Aug 7, 2025 | -$0.23 | -$0.25 | Miss -8.70% | — |
| May 8, 2025 | -$0.77 | -$0.30 | Beat 61.04% | — |
| Mar 20, 2025 | -$0.92 | -$0.74 | Beat 19.57% | — |
| Oct 30, 2024 | -$1.00 | -$1.03 | Miss -3.00% | — |
| Aug 13, 2024 | -$0.98 | -$1.01 | Miss -3.06% | — |
| May 10, 2024 | -$1.18 | -$1.11 | Beat 5.93% | — |
| Mar 29, 2024 | -$1.60 | -$0.24 | Beat 85.00% | — |
| Nov 13, 2023 | -$0.10 | -$1.60 | Miss -1500.00% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 29, 2026